331 filings
Page 4 of 17
EFFECT
8vtqqioj1mv
12 Nov 20
Notice of effectiveness
12:15am
UPLOAD
jzlexpq5gal3yp3gr
6 Nov 20
Letter from SEC
12:00am
CORRESP
ru3vxvfroe3ijh 7c
6 Nov 20
Correspondence with SEC
12:00am
8-K
bfjwvab95
30 Oct 20
Entry into a Material Definitive Agreement
4:40pm
424B5
mv4yg3vpozemuo8ox80d
30 Oct 20
Prospectus supplement for primary offering
4:32pm
8-K
5510p5aq 5at56di
21 Sep 20
Fennec Announces Issuance of U.S. Patent for Pedmarktm
12:57pm
8-K
8dq9hx7 5w8p6xkbmjc
11 Aug 20
Other Events
10:18am
8-K
s7ma yk6dxof7q5qse
26 Jun 20
Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
4:13pm
8-K
syxvkr8at4
23 Jun 20
Submission of Matters to a Vote of Security Holders
3:49pm
8-K
v9cy taokmjzd60
4 May 20
Fennec Announces Proposed Public Offering of Common Shares
12:00am
424B5
0h0bgl2 ngtx
1 May 20
Prospectus supplement for primary offering
5:28pm
424B5
sbwjcmt0jp0mywm6el9
29 Apr 20
Prospectus supplement for primary offering
4:48pm
8-K
4ema v9sqohfb2
13 Apr 20
Fennec Pharmaceuticals Announces Fda Filing Acceptance and Priority Review of New Drug Application for Pedmarktm
5:09pm
8-K
kb76bpu55h ve4n28i
5 Mar 20
Fennec Announces Issuance of U.S. Patent for Use of Pedmarktm
1:18pm
8-K
djn svefhgmib
28 Feb 20
Fennec Pharmaceuticals Receives European Medicines Agency Validation for Marketing Authorization Application for Sodium Thiosulfate
10:28am
8-K
d247bep
14 Feb 20
Fennec Provides Business Update and Announces Fiscal Year 2019 Financial Results
11:40am